These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 199093)

  • 41. Lack of virulence of the murine fibroblast adapted strain, Kentucky A (KyA), of equine herpesvirus type 1 (EHV-1) in young horses.
    Matsumura T; O'Callaghan DJ; Kondo T; Kamada M
    Vet Microbiol; 1996 Feb; 48(3-4):353-65. PubMed ID: 9054131
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Equine rhinopneumonitis vaccine: immunogenicity and safety in foals.
    Purdy CW; Porter RC; Ford SJ
    Am J Vet Res; 1978 May; 39(5):745-52. PubMed ID: 215062
    [No Abstract]   [Full Text] [Related]  

  • 43. Equine herpesvirus type 2: cell-virus relationship during persistent cell-associated viremia.
    Gleeson LJ; Coggins L
    Am J Vet Res; 1985 Jan; 46(1):19-23. PubMed ID: 2982296
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inoculation of mares and very young foals with EHV-1 glycoproteins D and B reduces virus shedding following respiratory challenge with EHV-1.
    Foote CE; Raidal SL; Pecenpetelovska G; Wellington JE; Whalley JM
    Vet Immunol Immunopathol; 2006 May; 111(1-2):97-108. PubMed ID: 16504306
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Experimental infection with neuropathogenic equid herpesvirus type 1 (EHV-1) in adult horses.
    Goehring LS; van Maanen C; Berendsen M; Cullinane A; de Groot RJ; Rottier PJ; Wesselingh JJ; Sloet van Oldruitenborgh-Oosterbaan MM
    Vet J; 2010 Nov; 186(2):180-7. PubMed ID: 19726209
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro and in vivo characterization of equine herpesvirus type 1 (EHV-1) mutants devoid of the viral chemokine-binding glycoprotein G (gG).
    von Einem J; Smith PM; Van de Walle GR; O'Callaghan DJ; Osterrieder N
    Virology; 2007 May; 362(1):151-62. PubMed ID: 17250864
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Application of the passive hemagglutination test to the study of equine rhinopneumonitis. II. Serologic study in horses].
    Berrios P; Ibarra L; Riquelme S
    Rev Latinoam Microbiol; 1986; 28(4):339-43. PubMed ID: 3035677
    [No Abstract]   [Full Text] [Related]  

  • 48. Live-attenuated recombinant equine herpesvirus type 1 (EHV-1) induces a neutralizing antibody response against West Nile virus (WNV).
    Rosas CT; Tischer BK; Perkins GA; Wagner B; Goodman LB; Osterrieder N
    Virus Res; 2007 Apr; 125(1):69-78. PubMed ID: 17241683
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Equine herpesvirus-1 suppresses type-I interferon induction in equine endothelial cells.
    Sarkar S; Balasuriya UB; Horohov DW; Chambers TM
    Vet Immunol Immunopathol; 2015 Oct; 167(3-4):122-9. PubMed ID: 26275803
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influence of long-term equine herpesvirus type 1 (EHV-1) infection on primary murine neurons-the possible effects of the multiple passages of EHV-1 on its neurovirulence.
    Cymerys J; Słońska A; Tucholska A; Golke A; Chmielewska A; Bańbura MW
    Folia Microbiol (Praha); 2018 Jan; 63(1):1-11. PubMed ID: 28409422
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Monitoring and detection of acute viral respiratory tract disease in horses.
    Mumford EL; Traub-Dargatz JL; Salman MD; Collins JK; Getzy DM; Carman J
    J Am Vet Med Assoc; 1998 Aug; 213(3):385-90. PubMed ID: 9702229
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Equid herpesvirus type-1 exhibits neurotropism and neurovirulence in a mouse model.
    Mori CM; Mori E; Favaro LL; Santos CR; Lara MC; Villalobos EM; Cunha EM; Brandao PE; Richtzenhain LJ; Maiorka PC
    J Comp Pathol; 2012; 146(2-3):202-10. PubMed ID: 21689826
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Letter: Efficacy of modified live-virus equine rhinopneumonitis vaccine.
    Stear RL; Bass EP; Beckenhauer WH
    Am J Vet Res; 1976 Mar; 37(3):349-51. PubMed ID: 176909
    [No Abstract]   [Full Text] [Related]  

  • 54. Growth of recombinant equine herpesvirus 1 (EHV-1) replaced with passage-induced mutant gene 1 and gene 71 derived from an attenuated EHV-1 in cell cultures and in the lungs of mice.
    Kirisawa R; Kobayashi T; Uematsu R; Ikeda A; Kuroiwa R; Urakami A; Iwai H
    Vet Microbiol; 2003 Sep; 95(3):159-74. PubMed ID: 12935744
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunity to equine herpesvirus type 1 (rhinopneumonitis): in vitro lymphocyte response.
    Wilks CR; Coggins L
    Am J Vet Res; 1976 May; 37(5):486-92. PubMed ID: 179451
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuropathogenicity for suckling mice of equine herpesvirus 1 from the Lipizzan outbreak 1983 and of selected other EHV 1 strains.
    Nowotny N; Burtscher H; Bürki F
    Zentralbl Veterinarmed B; 1987 Aug; 34(6):441-8. PubMed ID: 2830747
    [No Abstract]   [Full Text] [Related]  

  • 57. Effect of age and pregnancy on the antibody and cell-mediated immune responses of horses to equine herpesvirus 1.
    Gerber JD; Marron AE; Bass EP; Beckenhauer WH
    Can J Comp Med; 1977 Oct; 41(4):471-8. PubMed ID: 200320
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serological evidence of equine herpesvirus type 1 (EHV-1) activity in polo horses in Nigeria.
    Adeyefa CA
    Zentralbl Veterinarmed B; 1992 Oct; 39(8):628-30. PubMed ID: 1334303
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Equine interferons following exposure to equid herpesvirus-1 or -4.
    Edington N; Bridges CG; Griffiths L
    J Interferon Res; 1989 Aug; 9(4):389-92. PubMed ID: 2474039
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Innate immune responses of airway epithelial cells to infection with equine herpesvirus-1.
    Soboll Hussey G; Ashton LV; Quintana AM; Lunn DP; Goehring LS; Annis K; Landolt G
    Vet Microbiol; 2014 May; 170(1-2):28-38. PubMed ID: 24560592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.